412
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Basic Science Offers a Challenge for Developing Hemoglobin Based Oxygen Carriers into Therapeutic Agents

Pages 206-213 | Published online: 22 Jun 2011

REFERENCES

  • Natanson, C., Kern, S.J., Lurie, P., Banks, S.M., Wolfe, S.M. (1998). Cell free hemoglobin-based blood substitutes and risk of myocardial infarctions and death. JAMA 299: 2304–12.
  • Bucci, E. (2009). Thermodynamic approach to oxygen delivery in vivo by natural and artificial oxygen carriers. Biophysical Chemistry 142:1–6.
  • Bucci E (2010) Oxygen delivery by natural and artificial oxygen carriers. Chemistry and Biochemistry of Oxygen Therapeutics: from transfusions to blood substitutes. Bettati, Mozzarelli, Wiley. In press.
  • Bucci, E., Watts, T.L., Kwansa, H.E., Fasano, A. (2003). A different efficacy in vitro of hemoglobin-based carriers and red cells. Adv. Exp. Med. Biol. 510:89–92.
  • Wittenberg, J.W. (1966). The molecular mechanism of hemoglobin-facilitated oxygen Diffusion. J. Biol. Chem. 241:104–114.
  • Urbaitis, B.K., Razynska, A., Corteza, Q., Fronticelli, C., Bucci, E. (1991). Intravascular retention and renal handling of purified natural and intramolecularly crosslinked hemoglobins. J. Lab. Clin. Med., 117:115–121.
  • Ulatowski, J.A., Nishikawa, T., Matheson-Urbaitis, B., Bucci, E., Traystman, R.J., Koehler, R.C. (1996). Regional blood flow alterations after bovine fumaryl beta beta-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition. Crit Care Med. 24:558–65.
  • Asano, Y., Koehler, R.C., Ulatowski, J.A., Traystman, R.J., Bucci, E. (1998). Effect of crosslinked hemoglobin transfusion on endothelial dependent dilation in feline pial arterioles. Am J Physiol Heart Circ Physiol 275: H1313–H1321.
  • Rippe, B., Haraldsson, B. (1994). Transport of macromolecules across microvascular walls the two-pore theory. Physiol Rev 74:163–219.
  • Sakai, H., Hara, H., Yuasa, M., Tsai, A.G., Takeoka, S., Tsuchida, E., Intaglietta, M. (2000). Molecular dimensions of Hb-based O2 carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol 279:H908–H915.
  • Cabrales, P., Sun, G., Zhou, Y., Harris, D.R., Tsai, A.G., Intaglietta, M., Palmer, A.F. (2009). Effects of the molecular mass of tense-state polymerized bovine hemoglobin on blood pressure and vasoconstriction. J Appl Physiol 107:1548–1558.
  • Matheson, B., Kwansa, H.E., Bucci, E., Rebel, A., Koehler, R.C. (2002). Vascular response to infusions of a nonextravasating hemoglobin polymer. J Appl Physiol 93: 1479–1486.
  • Yu, B., Raher, M., Volpato, G.P., Bioch, K.D., Ichinose, F., Zapol, W.M. (2008). Inhaled nitric oxide enables artificial blood transfusion without hypertension. Circulation 117: 1982–1980.
  • Kavdia, M., Popel, A.S. (2003). Wall shear stress differentially affects NO level in arterioles for volume expanders and Hb based O2 carriers. Microvasc Res. 66:49–58.
  • Ulatowski, J.A., Bucci, E., Nishikawa, T., Razynska, A., Williams, A., Takeshima, R., Traystman, R.J. and Koehler, R. C. (1996). Cerebral O2 transport with hematocrit reduced by cross-linked hemoglobin transfusion. Am. J. Physiol. (Heart Circ. Physiol. 39) 270:466–475.
  • Ulatowski, J.A., Bucci, E., Razynska, A., Traystman, R.J., Koehler, R.C. (1998). Cerebral blood flow during hypoxic hypoxia with plasma-based hemoglobin at reduced hematocrit. Am J Physiol 274:H1933–1942.
  • Rebel, A., Ulatowski, J.A., Kwansa, H., Bucci, E., Koehler, R.C. (2003). Cerebrovascular response to decreased hematocrit: effect of cell-free hemoglobin, plasma viscosity, and CO2. Am J Physiol Heart Circ Physiol. 285:H1600–H1608.
  • Sampei, K., Ulatowski, J.A., Asano, Y., Kwansa, H., Bucci, E., Koehler, R.C. (2005). Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion. Am J Physiol Heart Circ. Physiol. Sep; 289(3):H1191–1201.
  • Qin, X., Kwansa, H., Bucci, E., Roman, R.J., Koehler, R.C. (2006). Role of 20-HE TE in the pial arteriolar constrictor response to decreased hematocrit after exchange transfusion of cell-free polymeric hemoglobin. J. Appl Physiol. 100:336–342.
  • Page, T.C., Light, W.R., McKay, C.B., Hellums, J.D. (1998). Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobinbased oxygen carrier performance. Microvasc. Res. 55:54–64.
  • Baldwin, A.L. (1999). Modified hemoglobins produce venular interendothelial gaps and albumin leakage in the ratmesentery. Am. J. Physiol. 277:H650–H659.
  • Dull, R.D., DeWitt, B.J., Dinavahi, R., Schwartz, L., Hubert, C., Pace, N., Fronticelli, C. (2004). Quantitative assessment of hemoglobin-induced endothelial barrier dysfunction. J. Appl. Physiol. 97:1930–1937.
  • Bucci, E., Fronticelli, C. (1995). Hemoglobin intramolecularly cross-linked with long chain divalent reagents. U.S. Patent #5, 387, 672.
  • Fronticelli, C., Koehler, C. (2009). Design of recombinant hemoglobins for use in transfusion fluids. Crit. Care Clin. 25:357–71.
  • Koehler, R.C., Fronticelli, C., Bucci, E. (2008). Independence of oxygen transport on oxygen affinity of hemoglobin-based oxygen carriers. Biochem Biophys Acta 1784: 1387–94.
  • Kwansa, H.E., Arosio, D., Bucci, E. (2000). Adipyl crosslinked bovine hemoglobins as new models for allosteric transitions. Proteins: Structure, Function and Genetics 39:166–169.
  • Buehler, P.V., Boykins, R.A., Jia, Y., Norris, S., Freedberg, I.D., Alayash, A.I. (2003). Structural and functional characterization of glutaraldehyde-polymerized bovine hemoglobin and its isolated fractions. Anal. Chem. 77: 3466–3478.
  • Vandegriff, K.D., Malavalli, A., Wooldridge, J., Lohman, J., Winslow, R.M. (2003). MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion. 43:509–516.
  • Acharya, S.A., Friedman, J.M., Manjula, B.N., Intaglietta, M., Tsai, A.G., Winslow, R.M., Malavalli, A., Vandegriff, K., Smith, P.K. (2005). Enhanced molecular volume of conservatively pegylated Hb: (SP-PEG5K)6-HbA is non-hypertensive. Artif Cells Blood Substit Immobil Biotechnol. 33:239–55.
  • Vandegriff, K.D., Young, M.A., Lohman, J., Bellelli, A., Samaja, M., Malavalli, A., Winslow, R.M. (2008). CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats. Br. J. Pharmacol. 154:1649–1661.
  • Klaus, J.A., Kibler, K.K., Abuchowski, A., Koehler, R.C. (2010). Early treatment of transient focal cerebral ischemia with bovine PEGylated carboxy hemoglobin transfusion. Artif Cells Blood Substit Immobil Biotechnol. (in press). [Epub ahead of print].
  • Kawaguchi, A.T., Nakai, K., Fukumoto, D., Yamano, M., Haida, M., Tsukada, H. (2009). S-nitrosylated pegylated hemoglobin reduces the size of cerebral infarction in rats. Artif Organs 33:183–188.
  • Asanuma, H., Nakai, K., Sanada, S., . (2007). S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic hearts. J Mol Cell Cardiol 42: 924–930.
  • Motterlini, R., Clark, J.E., Foresti, R., Sarathchandra, P., Mann, B.E., Green, C.J. (2002). Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res. 90:E17–E24.
  • Yu, B., Shahid, M., Egorina, E.M., Sovershaev, M.A., Raher, M.J., Lei, C., Wu, M.X., Bloch, K.D., Zapol, W.M. (2010). Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by hemoglobin-based oxygen carrier. Anesthesiology. 112:586–594.
  • Kohmoto, J., Nakao, A., Stolz, D.B., Kaizu, T., Tsung, A., Ikeda, A., . (2007). Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway. Am J Transplant. 7:2279–2290.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.